|
|
540-1385 West 8th Ave
Vancouver, BC V6H 3V9 Canada
phone:
fax:
|
|
| Symbol |
|
| Exchange |
|
| Founded |
2003 |
| Employees |
|
|
|
| zymeworks.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| therapeutics for treating cancers, inflammatory & autoimmune diseases |
|
| Management |
| Dr. Ali Tehrani, President & CEO; Neil Klompas, CFO; Dr. Surjit Dixit, CTO; David Tucker, COO; Gordon Ng, Pre-clinical R&D. |
| |
|
|
|
|
|
|
| |
|
|
| Keywords |
| biotechnology, protein therapeutics, cancer, oncology, autoimmune disease, |
|
|
|
|
|
|
| Description |
|
Zymeworks Inc. is a biotechnology company committed to developing best-in-class protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases.
Zymeworks' approach combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silico experimentation and predictive protein optimization. Using this approach Zymeworks has developed multiple platform technologies to advance the field of biologics drug discovery and optimization. |
|
| Technology / Differentiation |
| ZymeCAD - a leading-edge molecular simulation platform for protein modeling and structure-guided optimization with the ability to relate the function and biophysical characteristics of a protein to its structure. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members